I agree that this site is using cookies. You can find further informations here.
X
Planchard, G.
56  results:
Search for persons X
?
1

Assessment of the current and emerging criteria for the his..:

Mathian, É. ; Drouet, Y. ; Sexton-Oates, A....
ESMO Open.  9 (2024)  6 - p. 103591 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Silicone-induced granuloma: A case report of atypical leg-u..:

Abergel, R. ; Picard, C. ; Planchard, G....
Annales de Dermatologie et de Vénéréologie.  149 (2022)  4 - p. 286-288 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Atteinte pulmonaire de pyoderma gangrenosum : discussion di..:

Gallou, S. ; Madelaine, J. ; Planchard, G....
La Revue de Médecine Interne.  42 (2021)  10 - p. 734-739 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Caractéristiques et évolution des atteintes ophtalmologique..:

Dumont, A. ; Lecannuet, A. ; Boutemy, J....
La Revue de Médecine Interne.  40 (2019)  - p. A53 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Factors associated with relapse and dependence to glucocort..:

Dumont, A. ; Delmas, C. ; Boutemy, J....
La Revue de Médecine Interne.  39 (2018)  - p. A101 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Real-world EGFR testing practices for non-small-cell lung c..:

Hofman, P ; Calabrese, F ; Kern, I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594022/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Multiomic analysis of malignant pleural mesothelioma identi..:

Mangiante, L ; Alcala, N ; Sexton-Oates, A...
http://edoc.mdc-berlin.de/23216/1/23216oa.pdf.  , 2023
Link: http://edoc.mdc-berlin.d..
 
?
8

Real-world EGFR testing practices for non-small-cell lung c..:

Hofman, P ; Calabrese, F ; Kern, I...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.esmoop.2023.101628.  , 2023
Link: https://serval.unil.ch/n..
 
?
9

Real-world EGFR testing practices for non-small-cell lung c..:

Hofman, P ; Calabrese, F ; Kern, I...
https://research.rug.nl/en/publications/cbc22bc4-6202-4943-a683-1f5d17b3ad4d.  , 2023
Link: https://hdl.handle.net/1..
 
?
10

A randomized phase II study of bortezomib and pemetrexed, i..:

Scagliotti, Giorgio V. ; Germonpré, Paul ; Bosquée, Leon...
Lung Cancer.  68 (2010)  3 - p. 420-426 , 2010
Link: https://doi.org/10.1016/..
 
?
11

Bookreviews:

Clark, R. P. ; Lilja, Einar ; Malmqvist, Eve...
International Review of Education.  9 (1963)  3 - p. 351-382 , 1963
Link: https://doi.org/10.1007/..
 
?
12

242P Prognostic role of tumor microenvironment features in ..:

Zullo, L. ; Marinello, A. ; Ghigna, M.R....
ESMO Open.  9 (2024)  - p. 102892 , 2024
Link: https://doi.org/10.1016/..
 
?
13

4O First-line (1L) osimertinib (osi) ± platinum-pemetrexed ..:

Valdiviezo, N. ; Okamoto, I. ; Hughes, B.G.M....
ESMO Open.  9 (2024)  - p. 102583 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Incidence of adverse events in older patients treated with ..:

Rached, L. ; Laparra, A. ; Aldea, M....
Journal of Geriatric Oncology.  14 (2023)  8 - p. S44-S45 , 2023
Link: https://doi.org/10.1016/..
 
?
15

P1.22-19 Determination of the Membranous Expression of cMET..:

Marinello, A. ; Ghigna, M.R. ; Mandarano, M....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S253-S254 , 2023
Link: https://doi.org/10.1016/..
 
1-15